Zila, Inc. (ZILAD) Reports a Q4 Loss
More News related to ZILAD
- Zila, Inc. (ZILAD) Reports a Q4 Loss
- Trading Radar for 10/6: IDT Corp. (IDT), Zila (ZILAD) Report
- Zila, Inc. (ZILAD) Retains William Blair & Company to Review Strategic Alternatives
More News related to Earnings
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Unusual 11 Mid-Day Movers 11/09: EONC, EWBC, REV, PRST Higher; GTN, CHNG, SRZ, CHDX Lower
- Notable Analyst Rating Changes: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
- Notable Mergers and Acquisitions of the Day 11/9: ERTS, GE/CMCSA, EWBC
Zila, Inc. (Nasdaq: ZILAD) reported financial results for its fiscal 2008 fourth quarter.
Net revenues increased 14% to $11.9 million compared with $10.4 million for the fourth quarter of fiscal 2007. (Consensus is $11.20 million)
Loss from continuing operations significantly narrowed to $2.4 million, or $0.26 per share, from a loss from continuing operations of $5.8 million, or $0.65 per share, for the fourth quarter of fiscal 2007. (Consensus is a loss of $0.28 - only 1 analyst)
Zila, Inc., a specialty pharmaceutical company, focuses on the prevention, detection, and treatment of oral diseases, primarily oral cancer. [SM]
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
